Advanced in Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A)

Dr. Lynda E. Polgreen

Pediatric Endocrinology
1201 W La Veta Ave, 
Orange, CA 
Advanced in Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A)
1201 W La Veta Ave, 
Orange, CA 
OverviewInsuranceLocationsClinical Research

Overview

Lynda Polgreen is a Pediatric Endocrinologist in Orange, California. Dr. Polgreen is rated as an Advanced provider by MediFind in the treatment of Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A). Her top areas of expertise are Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Osteotomy.

Her clinical research consists of co-authoring 62 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Endocrinology
Licenses
Pediatrics in CA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

1201 W La Veta Ave, Orange, CA 92868

Additional Areas of Focus

Dr. Polgreen has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Open-label Pilot Study of the Effects of Anakinra in Mucopolysaccharidosis (MPS) III
Open-label Pilot Study of the Effects of Anakinra in Mucopolysaccharidosis (MPS) III
Enrollment Status: Completed
Publish Date: October 22, 2024
Intervention Type: Biological
Study Drug: Anakinra
Study Phase: Phase 1/Phase 2
Phase 1/2 Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II, and VI
Phase 1/2 Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II, and VI
Enrollment Status: Active_not_recruiting
Publish Date: October 22, 2024
Intervention Type: Drug
Study Drug: Adalimumab
Study Phase: Phase 1/Phase 2
Longitudinal Study of Bone and Endocrine Disease in Children with MPS I, II, and VI: a Multicenter Study of the Lysosomal Disease Network.
Longitudinal Study of Bone and Endocrine Disease in Children with MPS I, II, and VI: a Multicenter Study of the Lysosomal Disease Network.
Enrollment Status: Completed
Publish Date: October 22, 2024
Pilot Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II and VI
Pilot Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II and VI
Enrollment Status: Completed
Publish Date: September 15, 2017
Intervention Type: Other, Drug
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

62 Total Publications

Fractures are Highly Correlated with Bone Density and Inversely Correlated with Bone Turnover Markers in Autosomal Dominant Osteopetrosis.
Fractures are Highly Correlated with Bone Density and Inversely Correlated with Bone Turnover Markers in Autosomal Dominant Osteopetrosis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: June 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Polgreen's expertise for a condition
ConditionClose
View All 8 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile